Literature DB >> 1791531

Three-dimensional structure and molecular dynamics of cis(Z)- and trans(E)-chlorprothixene.

I Sylte1, S G Dahl.   

Abstract

cis(Z)-Chlorprothixene has antidopaminergic potency, while trans(E)-chlorprothixene is virtually inactive. In order to reveal the structural features causing the difference in activity, the three-dimensional molecular and electronic structures of cis(Z)- and trans(E)-chlorprothixene were examined by computer graphics and molecular mechanical and quantum mechanical calculations. The internal molecular motions of the isomers were studied by molecular dynamics simulations in vacuo and in aqueous solution. The cis(Z)-isomer had lower potential molecular energy than the trans(E)-isomer, mainly due to electrostatic interactions within the side-chain and between the dimethylamino group and the chlorine atom. During molecular dynamics simulations in aqueous solution, the side-chain of the trans(E)-isomer stayed closer to the central S-C axis of the ring system than did the side-chain of the cis(Z)-isomer. The molecular electrostatic potentials were significantly lower in the vicinity of the chlorine atom in the trans(E)- than in the cis(Z)-isomer. Differences in molecular electrostatic potentials and in three-dimensional structure are suggested to be the main reasons for the difference in pharmacological activities of cis(Z)- and trans(E)-chlorprothixene.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1791531     DOI: 10.1002/jps.2600800805

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  2 in total

1.  Structural changes by sulfoxidation of phenothiazine drugs.

Authors:  S G Dahl; P A Kollman; S N Rao; U C Singh
Journal:  J Comput Aided Mol Des       Date:  1992-06       Impact factor: 3.686

2.  Molecular structure and dynamics of cis(Z)-and trans(E)-flupenthixol and clopenthixol.

Authors:  I Sylte; S G Dahl
Journal:  Pharm Res       Date:  1991-04       Impact factor: 4.200

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.